HK Stock MarketDetailed Quotes

LIFETECH SCI (01302)

Watchlist
  • 2.080
  • -0.040-1.89%
Not Open May 19 16:07 CST
9.63BMarket Cap59.43P/E (TTM)

LIFETECH SCI (01302) Revenue Breakdown Overview

By Business/Source

Currency:CNY
2025/FY
Stock NameRevenueRatio
Peripheral vascular disease business844.63M61.66%
Structural heart disease business511.68M37.35%
Pacing electrophysiology business13.48M0.98%

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Peripheral vascular disease business844.63M61.66%
Structural heart disease business511.68M37.35%
Pacing electrophysiology business13.48M0.98%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
The mainland of China973.35M71.06%
Europe165.86M12.11%
亚洲(不包括中国内地及印度)105.4M7.69%
India57.32M4.18%
South America39.74M2.90%
Africa22.87M1.67%
Other5.24M0.38%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More